Cabazitaxel ni umuti ukoreshwa mu kuvura kanseri, ukaba uri mu cyiciro cy'ibiyobyabwenge bita "paclitaxel analogues" .Iyi miti irashobora kubuza gukura no kugabana kw'uturemangingo tw’ibibyimba, bityo bikadindiza cyangwa bikabuza kanseri gutera imbere.
Cabazitaxel yavumbuwe bwa mbere n’abahanga mu kigo cy’igihugu cya kanseri muri Amerika. Nyuma y’imyaka myinshi y’ubushakashatsi n’iterambere, cabazitaxel yabaye imiti ikoreshwa cyane mu bikorwa by’ubuvuzi.Bishobora gukoreshwa mu kuvura ubwoko bwinshi bwa kanseri, harimo na kanseri y'ibere, kanseri yintanga, kanseri yibihaha itari ntoya, kanseri ya prostate, kanseri yigifu, kanseri yumura, nibindi.
Ihame ryo kuvura ryacabazitaxelni ukubuza gukura no gukwirakwira kwingirangingo yibibyimba bibangamira inzira ya Mitose. By'umwihariko, cabazitaxel irashobora guhuza na Tubulin kugirango irinde polymerisation na depolymerisation ya Tubuline, bityo bikagira ingaruka kuri Mitose ya selile yibibyimba, bigatuma selile zidashobora kugabana. no kwiyongera mubisanzwe, kandi amaherezo biganisha ku rupfu rw'uturemangingo.
Cabazitaxelni umuti wingenzi wa anticancer utanga ibyiringiro n amahirwe kubarwayi benshi kuvura kanseri. Hamwe niterambere ryiterambere rya siyanse nikoranabuhanga, hizera ko imikorere numutekano bya cabazitaxel bizarushaho kunozwa.
Gusoma mu buryo bwagutse: Hande Biotech imaze imyaka myinshi yibanda ku musaruro wa paclitaxel, kandi ni uruganda rwigenga rukora ibikoresho fatizo bya paclitaxel ku miti ikomoka ku bimera bivangwa n’ibiti byemejwe n’ibigo by’igihugu bigenzura nka Amerika FDA, Uburayi EDQM, Ositaraliya TGA, Ubushinwa CFDA, Ubuhinde, Ubuyapani, nibindiYunnan Hande atanga ubuziranengeCabazitaxelibikoresho fatizo, biboneka mububiko.Niba ubikeneye, nyamuneka twandikire igihe icyo aricyo cyose.
Igihe cyo kohereza: Jun-08-2023